These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7956350)

  • 1. Assignment of the human a-tropomyosin gene TPM3 to 1q22-->q23 by fluorescence in situ hybridisation.
    Wilton SD; Eyre H; Akkari PA; Watkins HC; MacRae C; Laing NG; Callen DC
    Cytogenet Cell Genet; 1995; 68(1-2):122-4. PubMed ID: 7956350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
    Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
    Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
    Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.
    Valent A; Danglot G; Bernheim A
    Eur J Hum Genet; 1997; 5(2):102-4. PubMed ID: 9195161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid physical mapping of the human trk protooncogene (NTRK1) to human chromosome 1q21-q22 by P1 clone selection, fluorescence in situ hybridization (FISH), and computer-assisted microscopy.
    Weier HU; Rhein AP; Shadravan F; Collins C; Polikoff D
    Genomics; 1995 Mar; 26(2):390-3. PubMed ID: 7601468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy.
    Laing NG; Wilton SD; Akkari PA; Dorosz S; Boundy K; Kneebone C; Blumbergs P; White S; Watkins H; Love DR
    Nat Genet; 1995 Jan; 9(1):75-9. PubMed ID: 7704029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assignment of the human beta tropomyosin gene (TPM2) to band 9p13 by fluorescence in situ hybridisation.
    Hunt CC; Eyre HJ; Akkari PA; Meredith C; Dorosz SM; Wilton SD; Callen DF; Laing NG; Baker E
    Cytogenet Cell Genet; 1995; 71(1):94-5. PubMed ID: 7606936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
    Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
    Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assignment of the human skeletal muscle alpha-tropomyosin gene (TPM1) to band 15q22 by fluorescence in situ hybridization.
    Eyre H; Akkari PA; Wilton SD; Callen DC; Baker E; Laing NG
    Cytogenet Cell Genet; 1995; 69(1-2):15-7. PubMed ID: 7835079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assignment of the human alpha-tropomyosin gene TPM4 to band 19p13.1 by fluorescence in situ hybridization.
    Wilton SD; Lim L; Dorosz SD; Gunn HC; Eyre HJ; Callen DF; Laing NG
    Cytogenet Cell Genet; 1996; 72(4):294-6. PubMed ID: 8641132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization of the human NTRK1 gene.
    Greco A; Villa R; Pierotti MA
    Oncogene; 1996 Dec; 13(11):2463-6. PubMed ID: 8957089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
    Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
    Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and organization of the human TRKA gene encoding a high affinity receptor for nerve growth factor.
    Indo Y; Mardy S; Tsuruta M; Karim MA; Matsuda I
    Jpn J Hum Genet; 1997 Jun; 42(2):343-51. PubMed ID: 9290260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31.
    Radice P; Sozzi G; Miozzo M; De Benedetti V; Cariani T; Bongarzone I; Spurr NK; Pierotti MA; Della Porta G
    Oncogene; 1991 Nov; 6(11):2145-8. PubMed ID: 1834975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2).
    Nakagawara A; Liu XG; Ikegaki N; White PS; Yamashiro DJ; Nycum LM; Biegel JA; Brodeur GM
    Genomics; 1995 Jan; 25(2):538-46. PubMed ID: 7789988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1.
    Laing NG; Wilton SD; Akkari PA; Dorosz S; Boundy K; Kneebone C; Blumbergs P; White S; Watkins H; Love DR
    Nat Genet; 1995 Jun; 10(2):249. PubMed ID: 7663526
    [No Abstract]   [Full Text] [Related]  

  • 18. TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemia.
    Rosati R; La Starza R; Luciano L; Gorello P; Matteucci C; Pierini V; Romoli S; Crescenzi B; Rotoli B; Martelli MF; Pane F; Mecucci C
    Leukemia; 2006 Sep; 20(9):1623-4. PubMed ID: 16838028
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.
    Akkari PA; Song Y; Hitchcock-DeGregori S; Blechynden L; Laing N
    Biochem Biophys Res Commun; 2002 Aug; 296(2):300-4. PubMed ID: 12163017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.
    Ardini E; Bosotti R; Borgia AL; De Ponti C; Somaschini A; Cammarota R; Amboldi N; Raddrizzani L; Milani A; Magnaghi P; Ballinari D; Casero D; Gasparri F; Banfi P; Avanzi N; Saccardo MB; Alzani R; Bandiera T; Felder E; Donati D; Pesenti E; Sartore-Bianchi A; Gambacorta M; Pierotti MA; Siena S; Veronese S; Galvani A; Isacchi A
    Mol Oncol; 2014 Dec; 8(8):1495-507. PubMed ID: 24962792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.